Explore the distinctions between Generative AI and Agentic AI. Understand how each works, their use cases, limitations, and ...

The Phase 1b/2a study will assess the safety of CNP-103 in adults (aged 18-35) and pediatrics (aged 12-17) who have Stage III or newly diagnosed (within the last 6 months) T1D as well as C-peptide ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat movement-related symptoms of Parkinson's disease, the drugmaker said on Tuesday.

Novo Nordisk said on Wednesday it plan to file its experimental next-generation obesity drug CagriSema for regulatory ...

By Ana Swanson and Chris Buckley The new president has left virtually no ... a month after both countries pledged to do more to block drugs and migrants. By Alan Rappeport What Does Trump ...

Two-time Grand Slam champion Simona Halep announced her retirement from tennis at age 33 after a first-round loss at a ...